Invera Wealth Advisors, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Invera Wealth Advisors, LLC
- $152 Million
- Q3 2025
A detailed history of Invera Wealth Advisors, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Invera Wealth Advisors, LLC holds 20,000 shares of LXRX stock, worth $25,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$25,000
Previous $19,000
42.11%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
128Shares Held
224MCall Options Held
431KPut Options Held
138K-
Artal Group S.A. Luxembourg, N4136MShares$170 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$48.6 Million1.9% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$12.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.52MShares$11.9 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.58MShares$5.72 Million0.03% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $236M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...